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The relationship between Nrf2/Keap1  
system and endoplasmic reticulum stress 
and inflammatory markers in peripheral 
blood mononuclear cells of type 2  
diabetic subjects
AbsTrAcT
Background. Oxidative stress, endoplasmic reticulum 
stress (ER stress), and inflammation are the main lead-
ing factors in the pathogenesis of type 2 diabetes. 
Nuclear factor erythroid 2-related factor 2 / Kelch-like 
EcH-associated protein 1 (Nrf2/Keap1) is the chief 
regulator of the antioxidant defense system that pro-
tects the cells against reactive oxygen species (ROS). 
ER stress and inflammatory pathways are involved in 
the suppression or the activation of the Nrf2/Keap1 
system. In this study, we aimed to explore the pos-
sible relationships of the main factors contributing 
to oxidative stress, endoplasmic reticulum stress, and 
inflammation in peripheral blood mononuclear cells 
(PBMCs) of diabetic patients. 
Methods. Levels of biological parameters, oxidative 
stress markers as well as the gene transcription of Nrf2, 
Keap1, p22phox, Chop1, Grp78, IL-6, and TNF-a were 
analyzed in the PbMcs of 32 type 2 diabetic and 31 
non-diabetic subjects. The correlation analysis was per-
formed for the markers of oxidative stress with selected 
ER stress-related genes and pro-inflammatory cytokines. 
Results. Fasting blood sugar (P < 0.0001), HbA1c 
(P < 0.0001), serum triglycerides (P = 0.024), insulin 
(P = 0.003), and HOMA2-IR (P = 0.016) were signifi-
cantly higher in diabetic patients compared with non-
diabetic subjects. Levels of malondialdehyde (MDA) 
and carbonyl content were higher in the diabetes 
group. Conversely, total thiol content, and ferric re-
duction of plasma was higher in the healthy group. 
The mRNA levels of Nrf2 were negatively correlated 
with Keap1 and IL-6 gene expression. We observed 
a significant positive correlation between mRNA levels 
of Chop1, Grp78, and Nrf2 transcription levels. 
Conclusion. The data of the present study suggest 
that the impaired function of the Nrf2/Keap1 system is 
associated with pathological factors such as ER stress 
and inflammation. (Clin Diabetol 2021; 10; 5: 394–402)
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Introduction
Type 2 diabetes mellitus (T2DM) is a metabolic 
disorder considered to be pandemic and its prevalence 
is rising drastically in both developed and developing 
countries. According to the estimates of the American 
Diabetes Association, approximately 451 million people 
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were afflicted with diabetes globally in 2017 and it is 
expected to rise to 693 million in 2045 [1]. 
It has been shown that oxidative stress has a great 
number of adversary effects on glucose homeostasis. 
Oxidative stress stimulates stress-responsive pathways 
and it is associated with the development of insulin 
resistance, pancreatic b-cell dysfunction, mitochondrial 
dysfunction, and atherosclerosis in people afflicted 
with diabetes [2–5]. Oxidative stress is described as 
a condition in which the equilibrium between produc-
tion and elimination of reactive oxygen species (ROS) is 
disturbed. Under physiological conditions, antioxidant 
constituents are capable to sustain the levels of ROS 
in normal ranges but in some pathological conditions 
such as T2DM and obesity, the capacity of this protec-
tive system is impaired due to excess amount of ROS 
[6]. Cells are already prepared for these possible injuries 
by equipping themselves with antioxidant defense 
mechanisms including phase II detoxifying and antioxi-
dant enzymes to combat ROS [7, 8]. The transcription 
factor nuclear factor erythroid 2-related factor 2 (Nrf2) 
with its negative regulator Kelch-like ECH-associated 
protein 1 (Keap1) plays a critical role in maintaining 
intracellular redox homeostasis [9, 10]. The mechanisms 
by which oxidative stressors induce disassociation of 
Nrf2 from Keap1 are explained elsewhere [11, 12]. It 
has been stated that binding of Nrf2 to the antioxidant 
responsive element (ARE) in the nucleus, mediates 
maintenance of redox status and antioxidant activity by 
inducing several antioxidant enzymes including perox-
iredoxin (PRX) families, thioredoxin (TRX), glutathione 
S-transferases (GST), cytosolic copper-zinc superoxide 
dismutase (CuZnSOD), mitochondrial manganese su-
peroxide dismutase (MnSOD) glutathione reductase 
(GR), and heme oxygenase-1 (HO-1) [7].
Endoplasmic reticulum stress is involved in the 
pathogenesis of T2DM. The ER is responsible for  fold-
ing of proteins in maturation steps of a protein [13]. 
There are specific sensors in ER trans-membrane which 
detect the unfolded or misfolded proteins. These sen-
sors are protein kinase-like ER kinase (PERK), inositol 
requiring kinase 1 (IRE1), and the transcriptional factor 
activating transcription factor 6 (ATF6) which are sus-
tained dormant by glucose-regulated protein 78 kDa 
(GRP78/BiP). Accumulation of unfolded and misfolded 
proteins in the ER is called ER stress. When ER stress 
occurs, unfolded protein response (UPR) attempts to 
overcome the crisis through disassociation of GRP78 
from ER trans-membrane sensors. In the case of UPR 
failure, the cell initiates apoptosis by activation of 
CCAAT/enhancer-binding protein homologous protein 
(CHOP) known as death factor [14, 15].
Chronic hyperglycemia as a stressor could trigger 
inflammatory responses in the tissues [16]. Inflamma-
tion is the first line in combating pathogens to return 
the damaged cell or tissue to its normal condition 
[17]. The initiation of inflammatory responses stimu-
lates the production of multiple pro-inflammatory 
cytokines and chemokines such as tumor necrosis 
factor a (TNF-a) and interleukin-6 (IL-6). It has been 
shown that TNF-a and IL-6 alter the b cells function 
and play a fundamental role in the development of 
insulin resistance [16, 18]. 
As mentioned earlier, oxidative stress, ER stress, and 
inflammation play key roles in the onset and develop-
ment of diabetes [7, 19]. However, less information 
are available about the interconnections of oxidative 
stress, ER stress, and inflammation in clinical settings. 
Therefore, in this study we aimed to investigate the 
interconnections of the mentioned factors in periph-
eral blood mononuclear cells (PBMCs) of diabetic and 
non-diabetic individuals. Understanding the exact 
mechanisms by which mentioned factors take part in 
the progression of T2DM will expand the opportunities 
in the probable future treatment of the disease.
Materials and methods
subject recruitment
This study was approved by the Ethics Committee 
of Tehran University of Medical Sciences and all partici-
pants gave written informed consent before the blood 
collection. Two groups of subjects were enrolled in the 
study: 31 non-diabetic control subjects and 32 type 2 
diabetic patients. Diabetes was defined as fasting 
glucose more than 126 mg/dl or use of hypoglycemic 
medication. Major requirements for non-diabetic 
control subjects were: the absence of diabetes and 
inflammatory diseases, and diabetic patients were en-
rolled in the study based on their previous records of 
diabetes. Exclusion criteria for diabetic patients were: 
diabetes type 1, insulin treatement, renal failure, and 
cancer. Fasting blood samples were collected in hep-
arinized tubes. 
Physical measurements
Standard methods were applied for the measure-
ment of height, weight, blood pressure, waist, and hip 
circumferences. Body mass index (BMI) was calculated 
by using the ratio of weight to the square of height 
in meters (kg/m2). Insulin resistance was estimated by 
Homeostatic Model Assessment of Insulin resistance 
(HOMA-IR), using the HOMA2 calculator software. 
HOMA2 calculator was downloaded from University 
of Oxford (www.dtu.ox.ac.uk).
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biochemical parameters
Venous blood samples were obtained from all 
the participants after an overnight fast, and the fresh 
blood was centrifuged at 3000 × g for 5 minutes, 
then plasma was held in -80oC for storage until as-
sayed. Biochemical analyses were done on BIOLIS 24i 
Premium Autoanalyser (Tokyo Boeki Machinery Ltd., 
Japan). The biochemical tests included fasting blood 
sugar (FBS), total cholesterol, LDL-C, HDL-C, triglycer-
ides, urea, uric acid, creatinine, total protein, serum 
glutamic oxaloacetic transaminase (SGOT), serum glu-
tamic pyruvic transaminase (SGPT), and high-sensitivity 
C-reactive protein (hsCRP). HbA1c was measured with 
HPLC method by the Tosoh G8 instrument (South San 
Francisco, CA), and insulin was measured by Insulin 
AccuBind ELISA Kit (Monobind Inc, California, USA). 
Relative mRNA expression of multiple genes associated 
with ER stress, oxidative stress, and inflammation was 
studied in the PBMCs of both groups. The obtained 
data from all the participants included age, sex, dura-
tion of diabetes, family history of diabetes and cancer, 
consumption of medications and alcohol, cigarette 
smoking, and history of myocardial infarction.
Assessment of oxidative stress biomarkers  
in serum
Malondialdehyde (MDA) as a product of lipid 
peroxidation was measured. The Thiobarbituric acid 
reactive substance (TBARS) method was used for the 
measurement of MDA, where MDA reacts with TBA and 
gives a pink-colored species that absorbs at 532 nm, as 
described elsewhere [20]. The ferric reducing antioxidant 
power (FRAP) assay was performed to determine the 
total antioxidant capacity (TAC) of plasma. This method 
is based on the reduction of ferric tripyridyltriazine (Fe 
III-TPTZ) complex to ferrous (Fe-II) ion formation by anti-
oxidants at low PH, and this coloration gives rise to the 
creation of a blue color, which absorbs at 593 nm [21]. 
Also, protein carbonyl content as a marker of oxidative 
damage was assessed by 2, 4-dinitrophenylhydrazine 
(DNPH) assay. In this method, protein carbonyl groups 
react with reagent DNPH and lead to the formation of 
2,4-dinitrophenyl (DNP) hydrazone product, which ab-
sorbs at 370 nm [22]. Total thiol content was assessed by 
the spectrophotometric method using 5,5’-dithiobis-(2-
nitrobenzoic) acid (DTNB) known as Ellman’s reagent. 
Thiol groups react with DTNB and generate 5-thio-
2-nitrobenzoic acid (TNB), which absorbs at 412 nm [23].
PbMc isolation
Whole blood collected in the heparinized tubes and 
was gently layered on the Ficoll–Hypaque density gradi-
ent and centrifuged at 800 g for 40 minutes. PBMCs 
were isolated and washed with PBS for three times 
and stored in -80 freezer prior to the RNA extraction.
rNA isolation and real-time Pcr
The total RNA was extracted from PBMCs by using 
the Gene-All Hybrid-R RNA purification kit and follow-
ing the manufacturer’s instructions (Gene-All Biotech-
nology Co., Seoul, South Korea). Reverse-transcription 
of RNA into cDNA was performed by using a Revert Aid 
RT Reverse Transcription Kit (Thermo Fisher, USA). The 
quantity of isolated RNA was measured by Nanodrop 
and the formaldehyde-agarose gel electrophoresis was 
applied for assessing the quality of RNA. Quantitative 
real-time PCR via the ABI machine was conducted by 
taking advantage of SYBR Green RealQ Plus 2 × Master 
Mix Green (Ampliqon). The duplicate values for each 
sample were used to validate the changes in the gene 
expression. The relative expression levels of mRNA 
encoding Nrf2, Keap1, Chop1, p22phox, Grp78, IL-6, 
and TNF-a were determined by using 2^-∆Ct method. 
ß-actin expression was used to normalize the differ-
ences in each sample. The NCBI primer Blast was used 
for designing of primer sequences. The forward and 
reverse sequences of primers are presented in Table 1.
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statistical analysis
All analyses were carried out by the Windows-based 
statistical program SPSS version 22 (SPSS Inc., Chicago, 
USA) and GraphPad Prism, version 6.0 (GraphPad Soft-
ware Inc., USA). All variables were checked for the nor-
mality of distribution with Kolmogorov Simonov test, 
and variables that scored under 0.05 in normality test, 
undergone logarithmic transformation prior to analysis. 
Values of variables are presented as mean ± SD for para-
metric variables, and nonparametric variables are shown 
as the median and the 25th to the 75th interquartile range. 
Differences between the groups were assessed by use of 
two-tailed unpaired Student’s t-test and Mann–Whitney 
U test. The ANOVA test was used for the correction of the 
confounding factors (age and weight). Pearson correlation 
and Spearman’s correlation analysis was performed to 
determine the relationship of variables with the expres-
sion of target genes, and also partial correlation was 
conducted to adjust for confounders. P-value < 0.05 was 
considered statistically significant.
Results
A total of 31 non-diabetic individuals and 32 dia-
betic patients were enrolled in this study. The clinical 
and biochemical characteristics of the study population 
are shown in Table 2. There is no meaningful difference 
between BMI and waist to hip ratio (WHR) variables 
of the study groups; however, their mean age varies 
significantly (p < 0.0001). On the one hand, fasting 
blood glucose (p < 0.0001), HbA1c (p < 0.0001), serum 
triglycerides (P = 0.024), insulin (P = 0.003), and HO-
MA2-IR (P = 0.016) values were significantly higher in 
diabetic patients compared with non-diabetic subjects. 
On the other hand, total cholesterol (p < 0.0001) and 
LDL-C (p < 0.0001) were significantly lower in diabetic 
patients, when compared to non-diabetic subjects. 
Also, it is worth mentioning that we did not observe any 
significant differences in mean values of HDL-C, urea, 
creatinine, and uric acid between the study groups.
Transcriptional analysis of oxidative stress mark-
ers uncovered that the gene expression of Keap-1 
Table 2. Clinical and biochemical characteristics of the study groups
Parameter Non-diabetic subjects (n = 31) Diabetic patients (n = 32) P-value
Age [years] 50.23 ± 6.63 56.81 ± 6.05 < 0.0001
Sex [M/F] 16/15 18/14 0.71
SBP [mm Hg] 120.93 ± 11.82 131.16 ± 17.43 0.009
DBP [mm Hg] 80.29 ± 9.40 81.03 ± 11.36 0.779
Weight [kg] 73.00 (70.00, 80.50) 77.50 (73.00, 95.25) 0.037
BMI [kg/m2] 26.20 (24.91, 29.75) 26.68 (25.63, 33.18) 0.274
Waist [cm] 97.22 ± 9.47 102.53 ± 11.63 0.052
Hip [cm] 105.16 ± 6.38 109.56 ± 10.54 0.05
WHR 0.92 ± 0.07 0.93 ± 0.06 0.301
FBS [mg/dL] 93.29 ± 7.6 141.22 ± 42.36 < 0.0001
HbA1c [%] 5.8 (5.5 , 6) 7.55 (6.62, 8.87) < 0.0001
HOMA2-IR 1.33 ± 1.1 1.71 ± 0.92 0.016
Total Chol [mg/dL] 184.77 ± 39.15 149 ± 30.6 < 0.0001
TG [mg/dL] 107.11 ± 39 137.74 ± 59.19 0.024
HDL-c [mg/dL] 47.23 ± 12.63 44.13 ± 12.18 0.325
LDL-c [mg/dL] 119.72 ± 28.95 89.44 ± 26.40 < 0.0001
Insulin [µU/mL] 9.36 ± 3.51 13.94 ± 7.32 0.003
Urea [mg/dL] 28.78 ± 9.45 31.26 ± 6.95 0.244
Creatinine [mg/dL] 0.84 ± 0.20 0.76 ± 0.17 0.105
Uric Acid[mg/dL] 5.47 ± 1.34 5.038 ± 1.42 0.213
hsCRP 1.4 (0.5, 3.22) 0.6 (0.30, 2.9) 0.319
Treatment with statins [%] — 68 —
Anti-hypertensive drugs [%] — 72 —
Metformin use [%] — 70 —
Sulphonylureas use [%] — 30 —
BMI — body mass index; Chol — cholesterol; DBP — diastolic blood pressure; FBS — fasting blood sugar; HbA1c — glycated hemoglobin; HDL — high den-
sity lipoprotein; HOMA2-IR — homeostatic model assessment of insulin resistance; hsCRP — high-sensitivity CRP; LDL — low density; SBP — systolic blood 
pressure; TG — triglyceride; WHR — waist to hip ratio; lipoprotein; P-values were calculated using student’s “t” test and Mann-Whitney “U” test
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and p22phox is significantly increased in the PBMCs of 
diabetic patients compared with the control group. 
Conversely, the data indicated that the gene expression 
of Nrf2 is significantly decreased in diabetic patients in 
comparison to non-diabetic subjects (Figure 1A). The 
relative mRNA expression of both ER stress markers 
(Grp-78 and Chop-1) was upraised in PBMCs of patients 
with diabetes compared to control subjects (Figure 1B). 
Also, genes of pro-inflammatory cytokines (IL-6 and 
TNF-a) were higher expressed in diabetic PBMCs com-
pared to non-diabetic cells (Figure 1C).
Analysis of oxidant markers in serum demonstrated 
that MDA (P = 0.0001) and carbonyl content (P = 0.002) 
have elevated extendedly in diabetic patients. Also these 
patients had lower levels of FRAP (P = 0.007) and total 
thiol (P = 0.002) (Table 3). These data strongly indicate 
that oxidative stress is more developed in the PBMCs of 
diabetic patients compared to the control group.
In order to investigate the connections of oxidative 
stress with ER stress and inflammation, we performed 
partial correlation analysis. Table 4 presents the data of 
partial correlation analysis between the relative expres-
sion of genes and oxidative stress markers. Adjustments 
were performed for age, BMI and drug consumption. 
The gene expression of Nrf2 was negatively correlated 
with MDA and carbonyl content. Conversely, mRNA 
levels of Nrf2 was positively associated with FRAP. 
Furthermore, the genes expression were found to be 
associated with each other significantly. Importantly, 
results showed a strong negative correlation of Nrf2 
with oxidative stress related genes (Keap1 and p22phox) 
and IL-6. Interestingly, there was a positive correlation 
between gene expression of Nrf2 and ER stress-related 
genes. Gene expression of oxidative stress related genes 
(Keap1 and p22phox) were positively correlated with 
inflammatory genes, ER stress related genes and MDA. 
Moreover, mRNA levels of ER stress related genes were 
evaluated in association with oxidative stress associated 
markers and inflammatory genes. The expression levels of 
Chop1 and Grp78 had correlation with MDA, IL-6 and TNF-a. 
Furthermore, pro-inflammatory genes, in a same fashion, 
showed association with MDA and carbonyl content. 
We also evaluated the correlation of clinical and 
biochemical parameters with selected gene expressions. 
As shown in Table 5, while Nrf2 had negative significant 
correlation with age, FBS and HbA1c, Keap1 showed 
0.0000 0.0000
Chop-1 TNF-a
P value = 0.002
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Figure 1. Transcription levels of (A) oxidative stress-associated genes, (b) ER stress-related genes, and (c) inflammatory genes 
after adjustment for age, BMI and drug consumption. Data are presented as mean ± SEM. The statistical significance of differ-
ences was calculated employing the software GraphPad Prism, version 6.0 (GraphPad Software Inc., USA), using one-way ANOVA. 
Results were considered significantly different when P-value < 0.05
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positive correlation with FBS. Another gene involved in 
oxidative stress, p22phox was associated with FBS and 
HbA1c. Concerning the ER stress related genes, Chop1 
and Grp78, both had positive correlation with FBS, 
HbA1c and TG. In addition, TNF-a was associated with 
BMI, FBS and HbA1c. 
Discussion
Now there are convincing shreds of evidence 
that T2DM is affecting human beings’ life drastically, 
therefore it seems that developing the best ways of 
management of the disease is substantial. Obesity, 
hypertension, aging, dyslipidemia, hyperglycemia, 
cigarette smoking, sedentary lifestyle, and family his-
tory of diabetes are the most known leading factors 
in the development of T2DM. Sustained hyperglycemia 
is associated with oxidative stress, inflammation, ER 
stress. It is required to consider the effects of oxidative 
stress, inflammation, ER stress, and many other factors 
in the pathogenesis of T2DM. However, most of these 
Table 3. Oxidative stress markers of the study groups
Parameter Non-diabetic subjects Diabetic patients P-value
MDA [µmol/l] 2.30 ± 0.39 3.35 ± 1.02 0.0001
FRAP [µmol/l] 882.60 ± 146.73 756.65 ± 134.81 0.007
Carbonyl protein [nmoL/mg protein] 7.83 ± 1.10 9.42 ± 1.83 0.002
Total thiol [µmol/L] 211.80 ± 61.05 155.37 ± 51.28 0.002
FRAP — ferric reducing ability of plasma; MDA — malondialdehyde; LDL — low density. P-values were calculated using student’s “t” test and Mann-Whitney 
“U” test
Table 4. Partial correlation of selected genes with oxidative stress markers in whole population
Nrf2 Keap1 P22phox Grp78 chop1 TNF-a IL-6 MDA FRAP Total thiol
Keap1 -0.291* — — — — — — — — —
p22phox -0.408* 0.376* — — — — — — — —
Grp78 0.315* 0.327* 0.404* — — — — — — —
Chop1 0.378* 0.378* 0.367* 0.579** — — — — — —
TNF-a 0.132 0.366* 0.423* 0.401* 0.405* — — — — —
IL-6 -0.365* 0.333* 0.389* 0.441* 0.414* 0.454** — — — —
MDA -0.353* 0.449** 0.514* 0.427* 0.443* 0.492* 0.548** — — —
FRAP 0.344* -0.368* -0.428* 0.191 0.014 -0.506** 0.200 -0.397* — —
Total thiol 0.193 0.072 0.044 0.011 0.114 -0.078 -0.410* -0.384* 0.359* —
Carbonyl -0.337* 0.073 -0.028 0.446* 0.065 0.104 0.516* 0.389* -0.401* -0.444*
*P-value < 0.05; **P-value < 0.01. P-values were calculated using student’s “t” test and Mann-Whitney “U” test
Table 5. Correlation of clinical and biochemical parameters with selected gene expressions
Variable Nrf2 Keap1 p22phox Grp78 chop1 TNF-a IL-6
Age -0.417* -0.070 0.039 0.039 0.120 0.082 0.120
BMI 0.048 0.073 0.020 0.230 -0.046 0.398* 0.420**
FBS -0.355** 0.276* 0.456** 0.453** 0.439** 0.347* 0.334*
Chol 0.272* -0.335* -0.119 -0.031 -0.090 -0.069 -0.399*
TG 0.175 0.265* 0.176 0.376* 0.322* 0.383* 0.139
HDL-c 0.143 -0.263* 0.008 -0.386* -0.360* -0.376* -0.463**
LDL-c 0.311* -0.314* -0.179 -0.065 -0.182 -0.122 -0.330*
HbA1c -0.301* 0.293 0.574** 0.367* 0.314* 0.459** 0.483**
*P-value < 0.05; **P-value < 0.01, the analysis was performed by ANCOVA test on whole population and all the analyses were adjusted for confounding 
variables. BMI — body mass index; Chol — cholesterol; FBS — fasting blood sugar; HbA1c — glycosylated haemoglobin; HDL — high density lipoprotein; 
TG — triglyceride
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factors are well-examined and explained in the previous 
studies, but the exploring roles of mentioned factors 
in clinical settings are in great demand. 
Our data revealed that many biological and clinical 
indexes are changed in diabetic patients. We found 
that the levels of serum cholesterol and LDL-C are lower 
in diabetic patients in comparison with the control 
group. We think that it might be associated with the 
consumption of lipid-lowering drugs in the diabetic 
group. Oxidative stress is one of the leading factors in 
the pathogenesis of T2DM. In this study, we assessed 
a series of oxidative stress markers in the serum of 
the subjects. Similar to previous reports [24–32], we 
observed rise in protein oxidation (protein carbonyls), 
lipid peroxidation (MDA), diminution of total thiol 
content, and decrease of total antioxidant capacity 
(FRAP) in diabetic patients compared to the healthy 
subjects. In this regard, we also analyzed the gene ex-
pression levels of oxidative stress related genes in the 
PBMCs of both groups. In accordance with findings of 
previous studies, transcriptional analysis of oxidative 
stress-related genes revealed that the gene expression 
of Nrf2 is reduced in the diabetes group, while mRNA 
levels of both Keap1 and p22phox were elevated in the 
diabetic group when compared to the healthy subjects 
[27, 33]. Similar to our findings, in the study of Rab-
bani et al. [34] the protein levels of Nrf2 and Keap1 
were decreased and increased, respectively. Also, it has 
been shown that Keap1 knockdown in diabetic bone 
marrow-derived cells resulted in Nrf2 upregulation. 
Concurrently, the downregulation of Nrf2 leads to ROS 
accumulation. In addition, the authors established the 
Nrf2/Keap1 as a cytoprotective pathway in the cells and 
the downregulation of Nrf2 leads to ROS accumulation. 
Furthermore, in agreement with the previous reports 
on important role of hyperglycemia in inducing oxida-
tive stress [35–37], we were able to demonstrate an 
association between Nrf2, Keap1 and p22phox expres-
sion levels with the glycemic indexes (FBS and HbA1c). 
Taken together, these findings suggest an impairment 
of the antioxidant defenses system in PBMCs of the 
diabetic patients. 
The main goal of our study was to investigate the 
correlations of oxidative stress, ER stress and inflam-
mation as these are the three main factors in the de-
velopment of insulin resistance and ß cell dysfunction 
in diabetic patients. Our data revealed that there is 
a positive correlation between the expression of Nrf2, 
Grp78, and Chop1 genes. In eukaryotic cells, folding 
and trafficking of almost all membrane proteins and 
most secreted proteins are executed in the endoplasmic 
reticulum. Moreover, ER is involved in the energy me-
tabolism, apoptosis, homeostasis of intracellular Ca2
+ 
and reduction–oxidation (redox) balance [38]. When 
the ER is under stress, ROS can be produced in the ER 
as a byproduct of oxidative protein folding. This inci-
dent can contribute to mitochondrial ROS production 
and cause oxidative stress. Recent insights have shown 
that ER and mitochondria are connected to each other 
by mitochondria-associated ER membranes (MAMs)
[39]. Therefore, the oxidative stress and ER stress are 
coexisted most of the time and induce each other. As 
we mentioned earlier, Nrf2 is a transcription factor that 
participates in cell survival mechanisms by induction 
of antioxidants genes such as superoxide dismutases 
(SODs), glutathione peroxidases, peroxiredoxins, and 
catalase. Collectively, in a stressed cell, Nrf2 pathway 
functions as a system to rescue cells from death by sup-
pressing both ER stress and oxidative stress. Consistent 
with this idea, we found that there is a positive rela-
tionship between oxidative stress and ER stress markers 
in the mRNA level in diabetic patients, indicating the 
interconnectivity of these parameters.
It has been shown that PBMCs are representative 
cells for studying inflammatory pathways, oxidative 
stress, dyslipidemia, and glucose metabolism[40]. 
Therefore, in this study, we used PBMCs as a model of 
inflammatory cells to determine the possible correla-
tions of inflammatory cytokines and oxidative stress 
markers. We observed a negative correlation between 
Nrf2 and IL-6 gene expressions. In a study by Thim-
mulappa et al. [41] LPS stimulation resulted in ROS 
production as well as a rise in the levels of TNF-a and 
IL-6 in peritoneal neutrophils of mice. However, the 
authors have declared that these factors are more 
elevated in nrf2 −/− cells compared to nrf2 +/+ cells, 
showing the protective role of Nrf2 against inflam-
mation. Moreover, the authors have stated that the 
effects of pro-inflammatory cytokines on nrf2 −/− neu-
trophils are mediated through ROS signaling [41]. In 
the present study unlike for IL-6, we did not observe 
any significant correlation between Nrf2 and TNF-a. 
Considering former studies, there are contradictory 
findings regarding the correlation between Nrf2 and 
TNF-a. In a study by Gobinath Shanmugam et al. [42] 
it was shown bimodal effects of TNF-a on Nrf2 in HL-1 
cardiomyocytes. Treatment of cells with 2–5 ng/mL of 
TNF-a increased importation of Nrf2 into the nucleus. 
Conversely, higher doses of TNF-a (>10–50 ng/ml) re-
pressed gene expression of Nrf2. The authors concluded 
that the oxidative response of Nrf2 has two phases 
and the second phase is regulated by the other factors 
than Nrf2[42]. In Nrf2 (−/−) mice the gene expression 
of TNF-a was increased significantly, showing the im-
portant role of Nrf2 in controlling inflammation [43]. 
It is of note that PBMCs in the present study were in 
Farshad Niazpour et al., Relationship between Nrf2/Keap1 system and endoplasmic reticulum stress
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the basal, but not stimulated state and this could be 
a reason for not observing a significant association 
between Nrf2 and TNF-a.  
In summary, hyperglycemia activates several signal-
ing pathways including ER-stress (increased Grp78 and 
Chop1), oxidative stress (increased p22phos, decreased 
Nrf2) and inflammation (increased TNF-a and IL-6). In 
addition, activation of each pathway is correlated with 
the activation of the two other pathways leading to 
induction of inflammatory responses in PBMCs cells. 
The interconnections of the ER-stress, oxidative stress 
and inflammation in PBMCs is shown in Figure 2. 
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